Immunophenotypic characteristics of T-LBL
| Case No. Age, y/Sex . | BCL-6 . | CD1a . | CD2 . | CD3 . | CD4 . | CD5 . | CD7 . | CD8 . | CD10 . | CD19 . | CD20 . | CD30 . | CD34 . | CD38 . | CD45RO . | TCRαβ . | TCRγδ . | TdT . | Ki-67 . | BCL2 . | BCLXL . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | + | + | + | + | + | + | + | + | − | − | − | − | − | + | + | + | − | + | + | + | ± |
| 37/M | > 90% | cyt | 40% | > 90% | |||||||||||||||||
| 2 | + | + | + | + | + | + | + | + | − | − | − | − | − | + | + | + | − | + | + | + | ± |
| 17/M | 80% | cyt | 100% | > 90% | |||||||||||||||||
| 3 | + | + | + | + | + | + | + | + | − | − | − | − | − | + | + | + | − | + | + | + | ± |
| 36/M | > 50% | cyt | |||||||||||||||||||
| 4 | + | + | + | + | − | + | + | − | − | − | − | − | − | + | + | − | − | + | + | + | + |
| 7/F | 50% | 40% | cyt | 20% | > 90% | ||||||||||||||||
| 5 | − | + | + | + | − | + | + | − | − | − | − | − | − | ND | + | − | ND | + | + | + | + |
| 8/M | 40% | cyt | 90% | 70% | |||||||||||||||||
| 6 | − | + | − | + | − | + | + | − | − | − | − | − | − | + | − | − | ND | + | + | + | + |
| 7/F | 20% | cyt | 25% | 50% | > 80% | ||||||||||||||||
| 7 | − | + | + | + | − | + | + | − | − | − | − | − | + | + | − | − | − | + | + | + | ± |
| 19/F | cyt | 20% | > 90% | ||||||||||||||||||
| 8 | − | − | + | + | + | + | + | − | − | − | − | − | − | + | − | − | − | + | + | + | + |
| 51/M | cyt < 5% | 80% | > 80% |
| Case No. Age, y/Sex . | BCL-6 . | CD1a . | CD2 . | CD3 . | CD4 . | CD5 . | CD7 . | CD8 . | CD10 . | CD19 . | CD20 . | CD30 . | CD34 . | CD38 . | CD45RO . | TCRαβ . | TCRγδ . | TdT . | Ki-67 . | BCL2 . | BCLXL . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | + | + | + | + | + | + | + | + | − | − | − | − | − | + | + | + | − | + | + | + | ± |
| 37/M | > 90% | cyt | 40% | > 90% | |||||||||||||||||
| 2 | + | + | + | + | + | + | + | + | − | − | − | − | − | + | + | + | − | + | + | + | ± |
| 17/M | 80% | cyt | 100% | > 90% | |||||||||||||||||
| 3 | + | + | + | + | + | + | + | + | − | − | − | − | − | + | + | + | − | + | + | + | ± |
| 36/M | > 50% | cyt | |||||||||||||||||||
| 4 | + | + | + | + | − | + | + | − | − | − | − | − | − | + | + | − | − | + | + | + | + |
| 7/F | 50% | 40% | cyt | 20% | > 90% | ||||||||||||||||
| 5 | − | + | + | + | − | + | + | − | − | − | − | − | − | ND | + | − | ND | + | + | + | + |
| 8/M | 40% | cyt | 90% | 70% | |||||||||||||||||
| 6 | − | + | − | + | − | + | + | − | − | − | − | − | − | + | − | − | ND | + | + | + | + |
| 7/F | 20% | cyt | 25% | 50% | > 80% | ||||||||||||||||
| 7 | − | + | + | + | − | + | + | − | − | − | − | − | + | + | − | − | − | + | + | + | ± |
| 19/F | cyt | 20% | > 90% | ||||||||||||||||||
| 8 | − | − | + | + | + | + | + | − | − | − | − | − | − | + | − | − | − | + | + | + | + |
| 51/M | cyt < 5% | 80% | > 80% |
Expression of the corresponding antigens is expressed as positive (+), negative (−), and variable (±). For some antigens, the approximate percentage of positive cells within the tumor cell population is provided.
ND indicates not done; cyt, cytoplasmic staining.